Giant virilising adrenal cortical carcinoma

Androgen secreting adrenocortical carcinoma (ACC) is a very rare disease with a poor prognosis. Approximately 80% of tumors are functional, most commonly secreting glucocorticoids. We herewith report a case of a huge functional ACC of the right adrenal gland in a 33-year-old female who presented with complaints of hirsutism, amenorrhea and an abdominal lump. On abdominal examination a large lump was palpable in the right hypochondrium reaching up to the umbilicus. Contrast-enhance computed tomography (CECT) revealed a mass in the right suprarenal region. The tumor measured 29 cm × 20 cm × 12 cm and weighed 7.8 kg, the largest reported case of ACC in the world to the best of our knowledge.

Neoplasia oncocítica adrenocortical de potencial maligno incierto: reporte de un caso / Adrenocortical oncocytic neoplasm with uncertain malignant potential: a case report

Resumen Objetivo Describir el caso clínico de una paciente con neoplasia oncocitica adrenocortical, tratado quirúrgicamente en una clínica de Lima, Perú. Caso clínico Paciente mujer de 26 años ingresa a emergencia por dolor abdominal inespecífico. Se evidencia tumoración de 15x14x12 cm dependiente de glándula suprarrenal izquierda por lo que se decide tratamiento quirúrgico. Al análisis patológico se evidencia neoplasia oncocítica de potencial maligno incierto. Discusión Las neoplasias oncocíticas adrenocorticales son entidades poco frecuentes, con escasos reportes de casos de esta enfermedad. Para clasificarlas, se usa la escala de Weiss modificada. Obtenemos una neoplasia oncocítica de potencial maligno incierto, cuyo tratamiento incluye la cirugía de resección de tumor y observación. Conclusión Considerar a las neoplasias oncocíticas dentro del diagnóstico diferencial de incidentalomas adrenales.

Objective To describe a case report of a oncocytic adrenocortical neoplasm, treated surgically in a clinic in Lima, Peru. Case report A 26-year-old woman is admitted to the emergency due to nonspecific abdominal pain. A tumor measuring 15x14x12 cm dependent on left adrenal gland is evidenced, so surgical treatment is decided. Pathological analysis evidences oncocytic neoplasia of uncertain malignant potential. Discussion Oncocytic adrenocortical neoplasms are rare entities, with few case reports of this disease. To classify them, the modified Weiss scale is used. We obtain an oncocytic neoplasm of uncertain malignant potential, whose treatment includes surgery for tumor resection and observation. Conclusion Consider oncocytic neoplasms within the differential diagnosis of adrenal incidentalomas.

Predictors of complication after adrenalectomy

ABSTRACT Purpose: To investigate risk factors for complications in patients undergoing adrenalectomy. Materials and Methods: A retrospective search of our institutional database was performed of patients who underwent adrenalectomy, between 2014 and 2018. Clinical parameters and adrenal disorder characteristics were assessed and correlated to intra and post-operative course. Complications were analyzed within 30-days after surgery. A logistic regression was performed in order to identify independent predictors of morbidity in patients after adrenalectomy. Results: The files of 154 patients were reviewed. Median age and Body Mass Index (BMI) were 52-years and 27.8kg/m2, respectively. Mean tumor size was 4.9±4cm. Median surgery duration and estimated blood loss were 140min and 50mL, respectively. There were six conversions to open surgery. Minor and major post-operative complications occurred in 17.5% and 8.4% of the patients. Intra-operative complications occurred in 26.6% of the patients. Four patients died. Mean hospitalization duration was 4-days (Interquartile Range: 3-8). Patients age (p=0.004), comorbidities (p=0.003) and pathological diagnosis (p=0.003) were independent predictors of post-operative complications. Tumor size (p<0.001) and BMI (p=0.009) were independent predictors of intra-operative complications. Pathological diagnosis (p<0.001) and Charlson score (p=0.013) were independent predictors of death. Conclusion: Diligent care is needed with older patients, with multiple comorbidities and harboring unfavorable adrenal disorders (adrenocortical carcinoma and pheocromocytoma), who have greater risk of post-operative complications. Patients with elevated BMI and larger tumors have higher risk of intra, but not of post-operative complications.

Carcinoma adrenocortical oncocítico virilizante / Adrenal oncocytic virilizing carcinoma

Las neoplasias oncocíticas se encuentran raramente en la glándula suprarrenal. Suelen ser benignos y no funcionales. Existen informes extremadamente limitados de neoplasias oncocíticas suprarrenales. Alrededor del 20% de las neoplasias oncocíticas adrenocorticales muestran componentes malignos y el 10-20% produce hormonas que pueden causar desbalances hormonales. Se presenta un carcinoma adrenocortical oncocítico virilizante en mujer de 35 años de edad quien acudió a consulta por presentar hipomenorrea secundaria de seis meses de duración acompañada de hirsutismo y agravamiento del acné que afectaba principalmente la cara. El examen de laboratorio revela niveles elevados de testosterona libre. La tomografía computada mostró tumor multinodular en la glándula suprarrenal derecha con necrosis central y sin evidencia de linfadenopatía o invasión de estructuras que la rodeaban. Se programó la adrenalectomía derecha lográndose resección completa del tumor. Después de la cirugía, se normalizaron los ciclos menstruales, el hirsutismo, el acné y el resto de las pruebas. El examen histopatológico del tumor fue compatible con carcinoma adrenocortical oncocítico(AU)

Oncocytic neoplasms are found more rarely in the adrenal gland. They are usually benign and nonfunctional. There are limited reports of adrenal oncocytic neoplasms. About 20% of adrenocortical oncocytic neoplasms show malignant components and 10-20% produce hormones that can cause hormonal imbalances. We present a virilizing oncocytic adrenocortical carcinoma in a 35-year-old woman who consulted for hypomenorrhea accompanied by hirsutism and face acne worsening. Laboratory test revealed high levels of free testosterone. Computed tomography showed multinodular tumor of the right adrenal gland with central necrosis and without evidence of lymphadenopathy or invasion of surrounding structures. A right adrenalectomy was performed. After surgery, menstrual cycle, hirsutism and acne, as well as hormonal tests were normal. Histopathological examination of tumor showed an oncocytic adrenocortical carcinoma(AU)

Primary malignant tumors of the adrenal glands

Malignancy must be considered in the management of adrenal lesions, including those incidentally identified on imaging studies. Adrenocortical carcinomas (ACCs) are rare tumors with an estimated annual incidence of 0.7-2 cases per year and a worldwide prevalence of 4-12 cases per million/year. However, a much higher incidence of these tumors (>15 times) has been demonstrated in south and southeastern Brazil. Most ACCs cause hypersecretion of steroids including glucocorticoids and androgens. ACC patients have a very poor prognosis with a 5-year overall survival (OS) below 30% in most series. Pheochromocytoma or paraganglioma (PPGL) is a metabolically active tumor originating from the chromaffin cells of the adrenal medulla. The incidence of PPGL is 0.2 to 0.9 cases per 100,000 individuals per year. Pheochromocytomas are present in approximately 4-7% of patients with adrenal incidentalomas. Classically, PPGL manifests as paroxysmal attacks of the following 4 symptoms: headaches, diaphoresis, palpitations, and severe hypertensive episodes. The diagnosis of malignant PPGL relies on the presence of local invasion or metastasis. In this review, we present the clinical and biochemical characteristics and pathogenesis of malignant primary lesions that affect the cortex and medulla of human adrenal glands.

Adrenal Cortical Scintigraphy for Lateralization of Bilateral Adrenal Nodules in Primary Aldosteronism

No abstract available.

Adrenocortical oncocytoma

Adrenocortical oncocytoma is an exceedingly rare pathological variant of an adrenal neoplasm. The pathogenesis of oncocytic neoplasms is poorly understood. Females have been reported to be affected 2.5 times more frequently than males, and left-sided lesions are more common than those on right side. This case describes a 20 years old female with right lumbar pain. She found to have a right adrenal gland mass measuring about 6 x 5 cm. A computed tomogram showed hypodense mass lesion 6 x 4.2 cm involving right adrenal gland. Differential diagnosis of non-functional adrenal adenoma was made. A laparoscopic right adrenalectomy was performed using the 3-ports lateral transperitoneal approach. Histopathology showed adrenocortical oncocytoma of adrenal gland

Escore clínico-patológico para predizer o risco de metástases e recorrência local em pacientes com carcinoma cortical adrenal e papel do algoritmo da reticulina na distinção entre adenomas e carcinomas corticais adrenais / Clinicopathological score for predicting the risk of metastases and local recurrence in patients with adrenal cortical carcinoma and role of the reticulin algorithm in distinguishing between adrenal cortical adenomas and carcinomas

INTRODUÇÃO: o padrão-ouro para o diagnóstico histológico dos tumores corticais adrenais (TCAs) e sua diferenciação entre adenomas e carcinomas é o sistema de Weiss, cuja aplicação é limitada pela baixa reprodutibilidade de alguns dos critérios que o compõe. Recentemente foi proposto e validado um algoritmo diagnóstico para os TCAs baseado na integridade do arcabouço de reticulina e da membrana basal. Os carcinomas adrenais são tumores raros e apresentam prognóstico reservado, mesmo nos pacientes com doença aparentemente localizada. Além do estadiamento e da extensão da ressecção cirúrgica, outros dados foram reportados na literatura como tendo importância prognóstica, tais como idade ao diagnóstico, padrão funcional, tamanho tumoral, extensão local do tumor primário e alguns achados histológicos e imuno-histoquímicos, com destaque à taxa mitótica e ao índice de Ki-67. O sistema de Weiss, embora permita o diagnóstico diferencial entre adenomas e carcinomas, não foi testado completamente como uma ferramenta para distinguir os carcinomas com boa evolução clínica daqueles com desfecho desfavorável. OBJETIVOS: o presente estudo teve como objetivo primário construir um nomograma para estimar o risco de metástases e recorrência local em portadores de carcinoma adrenal, a partir de dados clínico-patológicos. O objetivo secundário foi avaliar o desempenho do algoritmo da reticulina no diagnóstico diferencial entre adenomas e carcinomas do córtex adrenal. MÉTODOS: para a construção do nomograma, foram analisados dados clínico-patológicos de 129 portadores de carcinomas adrenais atendidos no Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo entre 1976 e 2010. A avaliação do desempenho do algoritmo da reticulina para o diagnóstico histológico dos TCAs foi feita a partir do exame de 89 lâminas (45 adenomas e 44 carcinomas adrenais)...

INTRODUCTION: The gold standard for the histological diagnosis of adrenal cortical tumors (ACTs) and for the differentiation between adenomas and carcinomas is the Weiss system, whose application is limited by poor reproducibility of some of its criteria. Recently, a diagnostic algorithm for ACT diagnosis based on the integrity of the reticulin network and the basal membrane has been proposed and validated. Adrenal carcinomas are rare tumors and have a poor prognosis, even in patients with apparently localized disease. Besides tumor staging and extent of surgical resection, other data have been reported in the literature as having prognostic importance, such as age at diagnosis, the functional pattern, tumor size, local extension of the primary tumor and some histological and immunohistochemical findings, such as the mitotic rate and the Ki-67 index. The Weiss system, while allowing the differential diagnosis between adrenal cortical adenomas and carcinomas, has not been fully tested as a tool for distinguishing carcinomas with favorable clinical outcome from those with unfavorable outcome. OBJECTIVES: The primary objective of this study was to construct a nomogram for estimating the risk of metastasis and local recurrence in patients with adrenal cortical carcinoma, based on clinical and pathological data. The secondary objective was to evaluate the performance of the reticulina algorithm in the differential diagnosis between adenomas and carcinomas of the adrenal cortex. METHODS: For the construction of the nomogram, clinical and pathological data from 129 patients with adrenal cortical carcinomas treated at the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo between 1976 and 2010 were analyzed. The evaluation of the performance of the reticulin algorithm for the histological diagnosis of ACTs was made from the examination of 89 slides (45 adenomas and 44 adrenal carcinomas)...

Síndrome de Cushing secundario a carcinoma de la glándula suprarrenal izquierda con metástasis hepáticas y trombosis tumoral masiva de la vena cava / Cushing´s syndrome due to a left adrenal cortical carcinoma with metastasis to the liver and a massive vena cava tumor thrombus

Se presenta el caso de una mujer de 47 años con cuadro clínico de siete meses de evolución caracterizado por aumento progresivo de peso, hipertensión arterial y diabetes mellitus de reciente aparición, hirsutismo facial y en tórax, alopecia frontal, alteraciones en la menstruación e hipopotasiemia. Se consideró el diagnóstico de síndrome de Cushing, por lo cual se iniciaron estudios e extensión para establecer su etiología. Durante su hospitalización presentó una evolución tórpida y falleció. En la autopsia clínica se encontró un carcinoma de la glándula suprarrenal izquierda, de 400 g, aproximadamente, con metástasis a hígado y trombosis masiva de la vena cava, lo que finalmente produjo su muerte.

A 47-year-old woman with a seven-month history of increasing weight, hypertension and recently diagnosed diabetes presented features of hirsutism, frontal baldness, amenorrhea and hypokalemia. These characteristics were considered diagnostic of Cushing´s syndrome, and studies were initialized to identify its etiology. During hospitalization, the patient presented a torpid evolution resulting in death. Clinical autopsy revealed a 400 g carcinoma in the left adrenal gland, liver metastasis and a massive vena cava tumor thrombus which was the final cause of death.

Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor / Aspectos clínicos e moleculares de tumor adrenocortical metacrônico pediátrico

The occurrence of metachronous adrenocortical carcinoma has rarely been described. We report a case of a child with virilizing adrenocortical metachronous tumors that, despite several metastases, presented long-term survival (15 years). We analyzed in this tumor IGF2, IGF1R and FGFR4 gene expression, and evaluated the presence of p.R337H germline p53 mutation and somatic CTNNB1 mutation. IGF2 gene was over-expressed in both left (Weiss score 5) and right (Weiss 7) adrenocortical tumors. IGF1R expression levels were higher in the right adrenocortical tumor. FGFR4 over-expression was also detected in the right adrenocortical tumor. In addition, this patient harbors the germline p.R337H p53 mutation and loss of heterozygosity (LOH) was detected in the tumors. No somatic CTNNB1 mutations were found in both tumors. In conclusion, we demonstrated in this unusual case the over-expression of growth signaling pathways, which are molecular mechanisms previously related to adrenocortical tumorigenesis. Furthermore, the absence of somatic CTNNB1 mutations, which is a molecular marker of poor prognosis in adults, might be related to the long-term survival of this patient.

A ocorrência de carcinomas adrenocorticais metacrônicos é raramente relatada. Descrevemos o caso de uma criança portadora de tumor adrenocortical virilizante metacrônico que, apesar das inúmeras metástases, apresentou uma longa sobrevida (15 anos). Analisamos nesse tumor a expressão gênica de IGF2, IGF1R e FGFR4 e avaliamos a presença da mutação germinativa R337H no p53 e mutação somática no gene CTNNB1. O gene IGF2 foi hiperexpresso nos tumores adrenocorticais esquerdo (Weiss 5) e direito (Weiss 7). Os níveis de expressão de IGF1R foram maiores no tumor direito. Hiperexpressão do gene FGFR4 também foi observada no tumor adrenocortical direito. Esse paciente é portador da mutação germinativa R337H no p53, e perda de heterozigose (LOH) foi observada em ambos os tumores. Não foram encontradas mutações no gene CTNNB1 nos tumores. Em conclusão, demonstramos neste caso a hiperexpressão de vias moleculares de crescimento, que são mecanismos previamente relacionados à tumorigênese adrenocortical. Além disso, não encontramos mutações somáticas no gene CTNNB1, que é um marcador molecular de mau prognóstico em adultos e poderia estar relacionado à longa sobrevida desse paciente.

Carcinoma suprarrenal: [revisión] / Adrenocortical carcinoma: [review]

El carcinoma suprarrenal es una patología poco frecuente, con una incidencia anual estimada en 1-2 casos por millón de habitantes. Si bien se presenta a cualquier edad tiene una distribución bimodal, presentándose con mayor frecuencia antes de los 5 años y durante la cuarta y quinta décadas de vida. Tiene una leve tendencia a ser más frecuente en mujeres. Cerca del 60 por ciento de los casos se presentan como un tumor funcional asociado a un síndrome clínico reconocible. De estos los más frecuentes son el síndrome de Cushing y la virilización. El hiperaldosteronismo y la feminización son infrecuentes. Los pacientes con tumores no funcionales presentan un cuadro clínico producto del efecto de masa tumoral. Los estudios hormonales e imagenológicos son de vital importancia al momento de evaluar un paciente con sospecha de carcinoma suprarrenal. La adrenalectomía quirúrgica permanece como la única alternativa potencialmente curativa mientras que el Mitotano es el fármaco de elección en pacientes con tumores irresecables o enfermedad metastásica. El pronóstico del Carcinoma suprarrenal es malo, con una tasa de recurrencia de hasta el 80 por ciento y un promedio de sobrevida de 2 años.

Adrenocortical Carcinoma is an uncommon disease with an estimated incidence of 1-2 cases permillion people. Although it can occur at any age, it has a bimodal distribution, appearing more frequentlyin the first five years and during the fourth and fifth decades of life. It has a slight tendency to be more frequent in women. About 60 percent of cases are presented as a functional tumor associated with a recognizable clinical syndrome. Of these the most common are Cushing syndrome and virilization. The feminization and hyperaldosteronism are rare. Patients with a non-functional tumor present symptoms due to the tomoural mass effect. Hormonal and imaging studies are essential when assessing a patient with suspected adrenal carcinoma. Adrenalectomy remains as the only potentially curative treatment, whereas Mitotane is the drug of choice in patients with unresectable tumors or metastatic disease. The prognosis of adrenal carcinoma is poor, its rate of recurrence reaches 80 percent with an average survival of 2 years.

[Adrenocortical tumor in 20 months old female]

Adrecortical virilizing tumors are rare in the pediatric age group. There is 1% incidence for adneral cancer. In comparison with adult patients, there is function adrenalectomy tumor in pediatric group. The patient in this report was a 20 months old female presenting with clinical signs of virilizition that were characterized by increased bone mass, pubic hair growth external genitalia. The laboratory test showed: High level of testosterone [400 ng/dl], andrestandion [3.6ng/ml] and progestron [19.9ng/ml] and very high level of [8000ng/ml] dehydroepiandrosterone. In CT scan there was right adrenal mass with size>5 cm. The diagnosis of right an adrenocortical functional tumor led to the choice of open surgical adrenal with flank apreach between 10 and 11 ribs. Pathologic examination showed carcinoma of the adrenal. Patient discharged 5 days after operation. Surgery was done via lumbar incision and follow up was carreid out for 10 years, and there was not any pathological lesion

Carcinoma adrenocortical apresentando-se como massa abdominal / Adrenocortical carcinoma presenting as abdominal mass

O câncer adrenocortical (CAC) é um tumor raro com um prognóstico reservado. O CAC pode ser diagnosticado pela investigação de síndromes endócrinas, de sintomas devido ao crescimento tumoral ou de incidentaloma adrenal. A investigação hormonal demonstra na maioria dos CACs uma hipersecreção esteroidal, mas a característica dominante é uma co-secreção de cortisol e de andrógenos. A TC mostra um tumor heterogêneo e grande. Os tumores restritos à glândula adrenal têm uma evolução melhor do que tumores invasivos e metastáticos. A remoção completa do tumor é o tratamento de escolha. Nos pacientes com doença metastática ou progressiva, o tratamento com mitotano deve ser iniciado. Este relato de caso tem o intuito de demonstrar a importância do correto diagnóstico de lesões tumorais, pois têm grande influência no tratamento e prognóstico dos pacientes

Adrenocortical cancer (ACC) is a rare malign tumor with a poor prognosis. ACC can be diagnosed by the investigation of endocrine syndromes, signs and symptoms due to tumor growth or an adrenal incidentaloma. Hormonal investigations demonstrate in most ACC steroid oversecretion, but dominant characteristic being a co-secretion of cortisol and androgens. The CT shows a large heterogeneous tumor. Tumors localized to the adrenal gland have a better outcome than invasive and metastatic tumors. The complete tumor removal is the treatment of choice. In patients with metastatic or progressive disease, the treatment with mitotano must be initiated. This case has intention to demonstrate the importance of the correct diagnosis of tumors, therefore it has great influence in the treatment and prognosis of the patients

c-Ki-ras oncogene amplification and FGF2 signaling pathways in the mouse Y1 adrenocortical cell line

A linhagem tumoral Y1, originada de adrenocórtex decamundongo responde a FGF2 (Fator de Crescimento de Fibroblasto), possui o proto-oncogene c-ki-ras amplificado e a proteína c-Ki-Ras super-expressa e ativa (c-Ki-Ras-GTP). Em trabalhos anteriores mostramos que esta lesão genética causa ativação constitutiva da via de sinalização: c-Ki-Ras-GTP®PI3K®Akt (Forti et al. 2002). Por outro lado, a ativação da via de Raf® MEK®ERK, permanece estritamente dependente de estímulos de FGF2 (Rocha et al. 2003). Neste trabalho mostramos, primeiro, que estímulos de FGF2 ativam transientemente a via c-Ki-Ras-GTP®PI3K®Akt para níveis superiores aos expressos constitutivamente. Segundo, a ativação transiente de c-Ki-Ras-GTP por FGF2 permite a ativação da via de ERK1/2. Terceiro, os níveis basais elevados de c-Ki-Ras-GTP inibem a ativação da proteína c-H-Ras, pois células Y1 expressando o mutante negativo RasN17 apresentam uma rápida e transiente ativação de c-H-Ras-GTP após tratamentos de FGF2. Estes estudos das vias de sinalização acionadas por FGF2 em células adrenais tumorais Y1 podem fornecer novos alvos para o desenvolvimento de drogas de interesse para terapia oncogênica.

Adrenocotical carcinoma with invasion of inferior vena cava

Adrenal carcinomas are rare and the incidence of their extension to the inferior vena cava is between 15 to 20% of the cases. We report an adrenal carcinoma with a thrombosis to the inferior vena cava and we review the management of these cases which is essentially surgical and adapted to the extension of the thrombosis

Adrenocortical oncocytoma--a case report.

Oncocytic tumours of adrenal gland are rare lesions with approximately twenty-five cases being documented in literature. A majority of them are nonfunctional and benign. We report a case of adrenal oncocytoma in a 44-year-old male, who underwent a laparotomy for a large mass in the abdomen, which was located above the left kidney. Routine histopathological examination was suggestive of a benign tumour with cells resembling oncocytes. However, immunohistochemistry and electron microscopy helped to confirm the diagnosis of an adrenocortical oncocytoma.

Adenoma de Conn: uma causa de hipertensão e hipocalemia / Conn's adenoma: a cause of hypertension and hypokalemia

Hipertensão secundária corresponde aproximadamente a 5 a 10% das causas de hipertensão arterial e, entre elas, o hiperaldosteronismo primário apresenta uma incidência variável de 0,05 a 2% em hipertensos, com quadro característico de hipocalemia, produção aumentada de aldosterona, redução ou supressão da renina, relação aldosterona/renina elevada e alcalose metabólica. Descrevemos um caso de paciente com hipertensão arterial primária controlada, que apresentou na sua evolução um adenoma de supra-renal com piora dos níveis tensionais.

Aldosteronismo primário: é necessário sempre atençäo em busca do diagnóstico etiológico da hipertensäo arterial sistêmica / Primary aldosteronism: continuous attention is require for ethiologic diagnosis of essential hypertension

Paciente adulta jovem, com hipertensäo arterial sistêmica (HAS) crônica e miomatose uterina, internada no Hospital das Clínicas/UFMG para ser submetida à histerectomia. Evidenciou-se hipopotassemia e pressäo arterial elevada no pré-operatório, ambas refratárias à terapêutica medicamentosa. Surgiu diarréia líquida sem repercussöes sistêmicas ou evidências de etiologia infecciosa, que persistiu durante quase toda a internaçäo. A ultrassonografia revelou massa em topografia de glândula supra-renal esquerda. Foi realizada adrenalectomia através de videolaparoscopia, evidenciando-se melhora parcial dos níveis pressóricos no período pós-operatório. O potássio sérico normalizou-se e a diarréia desapareceu progressivamente. O exame anátomo-patológico da glândula revelou adenoma de supra-renal. O presente caso evidencia a necessidade de se manter postura crítica constante sobre a busca de explicaçäo para a hipertensäo arterial sistêmica.

Adenocarcinoma suprarrenal / Adrenocortical carcinoma

El adenocarcinoma de corteza suprarrenal es una neoplasia poco frecuente y agresiva que puede producir diversos síndromes endocrinológicos. Ante una enfermedad avanzada las expectativas de vida son de 9 por ciento a cinco años. Se ha propuesto que el tratamiento con o,p' DDD (mitotane) puede mejorar el pronóstico de estos pacientes. Se comunica el caso de un hombre de 43 años de edad, que inicialmente fue atendido por dolor en las fosas renales y edema de miembros pélvicos. En la tomografía axial computada se detectó una tumoración aparentemente renal. Durante la laparotomía exploradora se realizó una nefrectomía izquierda, donde se observó tumoración suprarrenal y lesión hepática metastásica. El diagnóstico de adenocarcinoma de corteza suprarrenal metastásico al hígado se confirmó mediante análisis patológico. Un mes después fue readmitido por desarrollo progresivo de anasarca, deshidratación y descontrol metabólico. El tratamiento se inició a base de mitotante a dosis escalatoria, sin lograr demostrar respuesta. Quince días después falleció en forma súbita por probable tromboembolia pulmonar. Se concluye que el tratamiento con mitotane puede tener efectos benéficos en el pronóstrico de esta neoplasia, sin embargo, los resultados son controvertidos. Actualmente, se investigan nuevas estrategias de tratamiento para el manejo de estos pacientes